NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022

W. Flaig, Thomas; E. Spiess, Philippe; Abern, Michael; Agarwal, Neeraj; Bangs, Rick; A. Boorjian, Stephen; K. Buyyounouski, Mark; Chan, Kevin; S. Chang, Sam; W. Friedlander, Terence; E. Greenberg, Richard; A. Guru, Khurshid; W. Herr, Harry; Hoffman‐Censits, Jean; U. Kishan, Amar; Kundu, Shilajit; M. Lele, Subodh; Mamtani, Ronac; Margulis, Vitaly; Y. Mian, Omar; M. Michalski, Jeff; S. Montgomery, Jeffrey; Nandagopal, Lakshminarayanan; C. Pagliaro, Lance; Parikh, Mamta; Patterson, Anthony; R. Plimack, Elizabeth; S. Pohar, Kamal; A. Preston, Mark; A. Richards, Kyle; J. Sexton, Wade; O. Siefker‐Radtke, Arlene; K. Tollefson, Matthew; D. Tward, Jonathan; L. Wright, Jonathan; A. Dwyer, Mary; J. Cassara, Carly; A. Gurski, Lisa

doi:10.6004/jnccn.2022.0041

Public

NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022

Published in Journal of the National Comprehensive Cancer Network • Aug 1, 2022

Authors:

Thomas W. Flaig

Philippe E. Spiess

Michael Abern

Abstract

The NCCN Guidelines for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer and other urinary tract cancers (upper tract tumors, urothelial carcinoma of the prostate, primary carcinoma of the urethra). These NCCN Guidelines I...

Subject

Medicine

Bladder cancer

Prostate cancer

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!